Market Trends of Germany Ultrasound Devices Industry
By Technology, High-intensity Focused Ultrasound Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Focused ultrasonic energy is a non-invasive method for tissue ablation, and it can be used to treat a variety of solid tumors. High-intensity focused ultrasound is utilized more frequently to treat primary and metastatic tumors because it can accurately identify tumors for ablation. Factors such as increasing cancer prevalence and initiatives by key players are expected to boost market growth.
For instance, according to the data published by Destatis in 2023, cancer was the fourth most frequent reason for treatment in Germany in 2021, accounting for 8% of all hospital stays. The source also stated that an estimated 1.44 million patients were treated for cancer in hospitals on an in-patient basis in Germany in 2021. Thus, the country's high cancer burden is expected to increase the usage of high-intensity focused ultrasound systems. Moreover, as cancer is often associated with older adults, the rising population in the country is also expected to enhance segment growth.
Moreover, according to an article published by PubMed in June 2022, a study in Germany showed that high-intensity focused ultrasound (HIFU) had high efficiency in treating benign thyroid nodules. This will result in a rise in the usage of HIFU systems in the German healthcare system for the radiation treatment of prostate cancer and other conditions, which is anticipated to fuel the expansion of high-intensity focused ultrasound systems there.
Hence, the factors mentioned above, such as the high burden of cancer, the growing geriatric population, and the increasing efficiency of high-intensity focused ultrasound systems, are expected to boost segment growth in the country.
By Application, Cardiology Segment is Expected to Hold a Significant Share in the Market Over the Forecast Period
Cardiovascular diseases such as heart failure, cardiac murmur, ischemic heart disease, and acute pulmonary artery thromboembolism are often diagnosed by ultrasound devices. The increasing prevalence of such diseases in Germany and the rising geriatric population in the country is expected to boost the segment growth.
For instance, according to an article published by the Thoracic and Cardiovascular Surgeon in June 2022, an estimated 92,838 heart surgery procedures were conducted in Germany in 2021. Thus, the country's large number of cardiovascular surgeries is expected to increase segment growth, as doctors often use ultrasound imaging before any cardiovascular procedure to diagnose the disease properly.
Moreover, the country's high percentage of the geriatric population is also expected to boost market growth as cardiovascular diseases are often associated with older people. For instance, according to the United Nations World Population Prospects data in 2022, an estimated 18.5 million people in Germany was 65 years or older in 2022.
Thus, the factors mentioned above, such as the high prevalence of cardiovascular diseases in Germany and the rising geriatric population, are expected to enhance segment growth.
